787619-52-7 Usage
Uses
Used in Pharmaceutical Industry:
(2-allyloxy-5-chloro-phenyl)methanol is used as a building block for the synthesis of various pharmaceuticals. Its unique structural properties and versatile reactivity make it suitable for the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
(2-allyloxy-5-chloro-phenyl)methanol is used as a key intermediate in the synthesis of agrochemicals. Its reactivity and structural properties allow for the development of new pesticides and other agricultural chemicals.
Used in Organic Synthesis:
(2-allyloxy-5-chloro-phenyl)methanol is used as a versatile building block in organic synthesis. Its allyloxy and chloro groups enable various chemical reactions, such as nucleophilic substitutions and cross-coupling reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Specialty and Fine Chemicals Production:
(2-allyloxy-5-chloro-phenyl)methanol has potential applications in the production of specialty and fine chemicals. Its unique structural properties and reactivity make it a promising candidate for the development of high-value chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 787619-52-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,7,6,1 and 9 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 787619-52:
(8*7)+(7*8)+(6*7)+(5*6)+(4*1)+(3*9)+(2*5)+(1*2)=227
227 % 10 = 7
So 787619-52-7 is a valid CAS Registry Number.
787619-52-7Relevant academic research and scientific papers
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
-
Page 20, (2010/02/09)
The invention provides compounds of Formula (I) the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein A, P, J, x, and R10 are as defined herein; pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions for the treatment of diseases, including, diabetes, including type 1 and type 2 diabetes, hyperglycemia, dyslipidemia, impaired glucose tolerance, metabolic syndrome, and/or cardiovascular disease.
